This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 101/6/560    most recent CIRCRESAHA.107.151068v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wang, Y. Articles by Tellides, G. Search for Related Content PubMed PubMed Citation Articles by Wang, Y. Articles by Tellides, G. Related Collections Cell signalling/signal transduction Growth factors/cytokines Smooth muscle proliferation and differentiation CV surgery: transplantation, ventricular assistance, cardiomyopathy Related Article

(Circulation Research. 2007;101:560.)
© 2007 American Heart Association, Inc.

Molecular Medicine

Interferon- Induces Human Vascular Smooth Muscle Cell Proliferation and Intimal Expansion by Phosphatidylinositol 3-Kinase–Dependent Mammalian Target of Rapamycin Raptor Complex 1 Activation

Yinong Wang, Yalai Bai, Lingfeng Qin, Pei Zhang, Tai Yi, Stephanie A. Teesdale, Liping Zhao, Jordan S. Pober, George Tellides

From the Interdepartmental Program in Vascular Biology and Transplantation, Departments of Surgery (Y.W., Y.B., L.Q., P.Z., T.Y., S.A.T., L.Z., G.T.) and Immunobiology (J.S.P.), Yale University School of Medicine, New Haven, Conn.

Correspondence to George Tellides, MD, PhD, 295 Congress Ave, BCMM 454, New Haven, CT 06510. E-mail george.tellides{at}yale.edu

Interferon (IFN)-, a cytokine characteristically expressed in arteriosclerotic diseases, acts directly on vascular smooth muscle cells to induce cellular proliferation and intimal expansion. Signaling by the mammalian target of rapamycin raptor complex, known as mTORC1, is associated with cell growth and is active within arteriosclerotic lesions but is not known to be triggered by proinflammatory factors in vascular smooth muscle cells. We investigated the mechanisms for the proarteriosclerotic effects of IFN- in the absence of leukocytes by exploiting the species specificity of this cytokine in a chimeric model of immunodeficient mouse recipients bearing human coronary artery grafts and intravenously inoculated with adenovirus encoding a human IFN- transgene. We found that IFN-–mediated vascular smooth muscle cell proliferation and intimal expansion were associated with phosphorylation of the mTORC1 effector ribosomal protein S6 kinase 1, that the graft morphological changes and S6 kinase 1 activation were inhibited by the mTORC1 inhibitor rapamycin in vivo, and that IFN-–induced mTORC1 signaling was dependent on phosphatidylinositol 3-kinase activity under serum-free conditions in vitro. Our work establishes an immunologic stimulus for mTORC1 signaling in vascular smooth muscle cells, emphasizes that mTORC1 activation is critical in immune-mediated vascular remodeling, and provides further mechanistic insight into the successful clinical application of rapamycin therapy for atherosclerosis and graft arteriosclerosis.

Key Words: arteriosclerosis • coronary arteries • cytokines • vascular smooth muscle cells

Related Article:

Interferon- and Intimal Hyperplasia

Marlene L. Rose
Circ. Res. 2007 101: 542-544. [Full Text] [PDF]

This article has been cited by other articles:

				S. A. Gerber and J. S. Pober IFN-{alpha} Induces Transcription of Hypoxia-Inducible Factor-1{alpha} to Inhibit Proliferation of Human Endothelial Cells J. Immunol., July 15, 2008; 181(2): 1052 - 1062. [Abstract] [Full Text] [PDF]

				M. L. Rose Interferon-{gamma} and Intimal Hyperplasia Circ. Res., September 14, 2007; 101(6): 542 - 544. [Full Text] [PDF]